Smith Nephew Snats Stock Performance
| SNN Stock | USD 25.66 0.35 1.38% |
Smith Nephew has a performance score of 2 on a scale of 0 to 100. The entity has a beta of 0.2, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Smith Nephew's returns are expected to increase less than the market. However, during the bear market, the loss of holding Smith Nephew is expected to be smaller as well. Smith Nephew SNATS right now has a risk of 1.25%. Please validate Smith Nephew semi variance, and the relationship between the treynor ratio and daily balance of power , to decide if Smith Nephew will be following its existing price patterns.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Smith Nephew SNATS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Smith Nephew is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
| Smith Nephew dividend paid on 8th of November 2024 | 11/08/2024 |
| Begin Period Cash Flow | 344 M |
Smith |
Smith Nephew Relative Risk vs. Return Landscape
If you would invest 2,524 in Smith Nephew SNATS on November 1, 2024 and sell it today you would earn a total of 42.00 from holding Smith Nephew SNATS or generate 1.66% return on investment over 90 days. Smith Nephew SNATS is generating 0.0352% of daily returns assuming volatility of 1.2524% on return distribution over 90 days investment horizon. In other words, 11% of stocks are less volatile than Smith, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Smith Nephew Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Smith Nephew's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Smith Nephew SNATS, and traders can use it to determine the average amount a Smith Nephew's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0281
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SNN |
Estimated Market Risk
| 1.25 actual daily | 11 89% of assets are more volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Smith Nephew is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Smith Nephew by adding it to a well-diversified portfolio.
Smith Nephew Fundamentals Growth
Smith Stock prices reflect investors' perceptions of the future prospects and financial health of Smith Nephew, and Smith Nephew fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Smith Stock performance.
| Return On Equity | 0.0584 | ||||
| Return On Asset | 0.0451 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 14.22 B | ||||
| Shares Outstanding | 435.99 M | ||||
| Price To Earning | 25.42 X | ||||
| Price To Book | 2.12 X | ||||
| Price To Sales | 1.97 X | ||||
| Revenue | 5.55 B | ||||
| EBITDA | 979 M | ||||
| Cash And Equivalents | 516 M | ||||
| Cash Per Share | 1.18 X | ||||
| Total Debt | 3.08 B | ||||
| Debt To Equity | 0.54 % | ||||
| Book Value Per Share | 5.96 X | ||||
| Cash Flow From Operations | 608 M | ||||
| Earnings Per Share | 0.70 X | ||||
| Total Asset | 9.99 B | ||||
| Retained Earnings | 4.91 B | ||||
| Current Asset | 532.7 M | ||||
| Current Liabilities | 428.5 M | ||||
About Smith Nephew Performance
By examining Smith Nephew's fundamental ratios, stakeholders can obtain critical insights into Smith Nephew's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Smith Nephew is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Smith Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. Smith Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom. Smith Nephew operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 18000 people.Things to note about Smith Nephew SNATS performance evaluation
Checking the ongoing alerts about Smith Nephew for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Smith Nephew SNATS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Smith Nephew SNATS has a poor financial position based on the latest SEC disclosures |
- Analyzing Smith Nephew's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Smith Nephew's stock is overvalued or undervalued compared to its peers.
- Examining Smith Nephew's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Smith Nephew's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Smith Nephew's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Smith Nephew's stock. These opinions can provide insight into Smith Nephew's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Smith Nephew SNATS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Smith Nephew. If investors know Smith will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Smith Nephew listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Smith Nephew SNATS is measured differently than its book value, which is the value of Smith that is recorded on the company's balance sheet. Investors also form their own opinion of Smith Nephew's value that differs from its market value or its book value, called intrinsic value, which is Smith Nephew's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Smith Nephew's market value can be influenced by many factors that don't directly affect Smith Nephew's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Smith Nephew's value and its price as these two are different measures arrived at by different means. Investors typically determine if Smith Nephew is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Smith Nephew's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.